-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal, A. et al. Global cancer statistics. CA: a cancer journal for clinicians 61, 69-90, doi: 10.3322/caac.20107 (2011).
-
(2011)
CA: A Cancer Journal for Clinicians
, vol.61
, pp. 69-90
-
-
Jemal, A.1
-
2
-
-
0037050352
-
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
-
Schiller, J. H. et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. The New England journal of medicine 346, 92-98, doi: 10.1056/NEJMoa011954 (2002).
-
(2002)
The New England Journal of Medicine
, vol.346
, pp. 92-98
-
-
Schiller, J.H.1
-
3
-
-
84872503488
-
Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy
-
Lindner, A. U. et al. Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy. Cancer research 73, 519-528, doi: 10.1158/0008-5472.CAN-12-2269 (2013).
-
(2013)
Cancer Research
, vol.73
, pp. 519-528
-
-
Lindner, A.U.1
-
4
-
-
0035060354
-
Is cisplatin-induced cell death always produced by apoptosis?
-
Gonzalez, V. M., Fuertes, M. A., Alonso, C. & Perez, J. M. Is cisplatin-induced cell death always produced by apoptosis? Molecular pharmacology 59, 657-663 (2001).
-
(2001)
Molecular Pharmacology
, vol.59
, pp. 657-663
-
-
Gonzalez, V.M.1
Fuertes, M.A.2
Alonso, C.3
Perez, J.M.4
-
5
-
-
0032575688
-
The Bcl-2 protein family: Arbiters of cell survival
-
Adams, J. M. & Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326 (1998).
-
(1998)
Science
, vol.281
, pp. 1322-1326
-
-
Adams, J.M.1
Cory, S.2
-
6
-
-
14044251695
-
Mitochondrial implication in apoptosis. Towards an endosymbiont hypothesis of apoptosis evolution
-
Kroemer, G. Mitochondrial implication in apoptosis. Towards an endosymbiont hypothesis of apoptosis evolution. Cell death and differentiation 4, 443-456, doi: 10.1038/sj.cdd.4400266 (1997).
-
(1997)
Cell Death and Differentiation
, vol.4
, pp. 443-456
-
-
Kroemer, G.1
-
7
-
-
0027166048
-
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
-
Oltvai, Z. N., Milliman, C. L. & Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619 (1993).
-
(1993)
Cell
, vol.74
, pp. 609-619
-
-
Oltvai, Z.N.1
Milliman, C.L.2
Korsmeyer, S.J.3
-
8
-
-
0030772022
-
Target to apoptosis: A hopeful weapon for prostate cancer
-
Tang, D. G. & Porter, A. T. Target to apoptosis: a hopeful weapon for prostate cancer. The Prostate 32, 284-293 (1997).
-
(1997)
The Prostate
, vol.32
, pp. 284-293
-
-
Tang, D.G.1
Porter, A.T.2
-
9
-
-
0034025130
-
Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas
-
Bukholm, I. K. & Nesland, J. M. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Archiv: an international journal of pathology 436, 224-228 (2000).
-
(2000)
Virchows Archiv: An International Journal of Pathology
, vol.436
, pp. 224-228
-
-
Bukholm, I.K.1
Nesland, J.M.2
-
10
-
-
1042299134
-
Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer
-
Linjawi, A., Kontogiannea, M., Halwani, F., Edwardes, M. & Meterissian, S. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. Journal of the American College of Surgeons 198, 83-90, doi: 10.1016/j.jamcollsurg.2003.08.008 (2004).
-
(2004)
Journal of the American College of Surgeons
, vol.198
, pp. 83-90
-
-
Linjawi, A.1
Kontogiannea, M.2
Halwani, F.3
Edwardes, M.4
Meterissian, S.5
-
11
-
-
34848892766
-
Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck
-
Chen, K. et al. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 28, 2008-2012, doi: 10.1093/carcin/bgm172 (2007).
-
(2007)
Carcinogenesis
, vol.28
, pp. 2008-2012
-
-
Chen, K.1
-
12
-
-
84876591115
-
Association of genetic markers in the BCL-2 family of apoptosis-related genes with endometrial cancer risk in a Chinese population
-
Dorjgochoo, T. et al. Association of genetic markers in the BCL-2 family of apoptosis-related genes with endometrial cancer risk in a Chinese population. PloS one 8, e60915, doi: 10.1371/journal.pone.0060915 (2013).
-
(2013)
PLoS One
, vol.8
, pp. e60915
-
-
Dorjgochoo, T.1
-
13
-
-
62049084351
-
Bcl2-938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy
-
Hirata, H. et al. Bcl2-938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy. The Journal of urology 181, 1907-1912, doi: 10.1016/j.juro.2008.11.093 (2009).
-
(2009)
The Journal of Urology
, vol.181
, pp. 1907-1912
-
-
Hirata, H.1
-
14
-
-
79953236337
-
BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility
-
Zhang, N. et al. BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility. BMC medical genetics 12, 48, doi: 10.1186/1471-2350-12-48 (2011).
-
(2011)
BMC Medical Genetics
, vol.12
, pp. 48
-
-
Zhang, N.1
-
15
-
-
84884760539
-
The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia
-
Kunkele, A. et al. The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia. BMC cancer 13, 452, doi: 10.1186/1471-2407-13-452 (2013).
-
(2013)
BMC Cancer
, vol.13
, pp. 452
-
-
Kunkele, A.1
-
16
-
-
84899065547
-
Association of BCL2-938C> A genetic polymorphism with glioma risk in Chinese Han population
-
Li, W., Qian, C., Wang, L., Teng, H. & Zhang, L. Association of BCL2-938C> A genetic polymorphism with glioma risk in Chinese Han population. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 35, 2259-2264, doi: 10.1007/s13277-013-1299-5 (2014).
-
(2014)
Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine
, vol.35
, pp. 2259-2264
-
-
Li, W.1
Qian, C.2
Wang, L.3
Teng, H.4
Zhang, L.5
-
17
-
-
33751541194
-
Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment
-
Rodriguez-Nieto, S. & Zhivotovsky, B. Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. Current pharmaceutical design 12, 4411-4425 (2006).
-
(2006)
Current Pharmaceutical Design
, vol.12
, pp. 4411-4425
-
-
Rodriguez-Nieto, S.1
Zhivotovsky, B.2
-
18
-
-
0344393783
-
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance
-
Kaufmann, S. H. & Vaux, D. L. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 22, 7414-7430, doi: 10.1038/sj.onc.1206945 (2003).
-
(2003)
Oncogene
, vol.22
, pp. 7414-7430
-
-
Kaufmann, S.H.1
Vaux, D.L.2
-
19
-
-
84866753909
-
Independent transcriptional reprogramming and apoptosis induction by cisplatin
-
Galluzzi, L. et al. Independent transcriptional reprogramming and apoptosis induction by cisplatin. Cell cycle 11, 3472-3480, doi: 10.4161/cc.21789 (2012).
-
(2012)
Cell Cycle
, vol.11
, pp. 3472-3480
-
-
Galluzzi, L.1
-
20
-
-
84873030541
-
Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapy
-
Masago, K. et al. Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapy. Oncology 84, 214-218, doi: 10.1159/000342854 (2013).
-
(2013)
Oncology
, vol.84
, pp. 214-218
-
-
Masago, K.1
-
21
-
-
79958008924
-
Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C> A) with better 2-year survival in patients with glioblastoma multiforme
-
El Hindy, N. et al. Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C> A) with better 2-year survival in patients with glioblastoma multiforme. Journal of neurosurgery 114, 1631-1639, doi: 10.3171/2010.12.JNS10478 (2011).
-
(2011)
Journal of Neurosurgery
, vol.114
, pp. 1631-1639
-
-
El Hindy, N.1
-
22
-
-
74849120847
-
BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients
-
Moon, J. H. et al. BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients. Leukemia research 34, 166-172, doi: 10.1016/j.leukres.2009.05.009 (2010).
-
(2010)
Leukemia Research
, vol.34
, pp. 166-172
-
-
Moon, J.H.1
-
23
-
-
71049131735
-
BCL2-938C> A polymorphism and disease progression in chronic lymphocytic leukemia
-
Zenz, T. et al. BCL2-938C> A polymorphism and disease progression in chronic lymphocytic leukemia. Leukemia & lymphoma 50, 1837-1842, doi: 10.3109/10428190903207530 (2009).
-
(2009)
Leukemia & Lymphoma
, vol.50
, pp. 1837-1842
-
-
Zenz, T.1
-
24
-
-
67649831321
-
The bcl2-938CC genotype has poor prognosis and lower survival in renal cancer
-
Hirata, H. et al. The bcl2-938CC genotype has poor prognosis and lower survival in renal cancer. The Journal of urology 182, 721-727, doi: 10.1016/j.juro.2009.03.081 (2009).
-
(2009)
The Journal of Urology
, vol.182
, pp. 721-727
-
-
Hirata, H.1
-
25
-
-
14944346868
-
Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated
-
Starczynski, J. et al. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 23, 1514-1521, doi: 10.1200/JCO.2005.02.192 (2005).
-
(2005)
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
, vol.23
, pp. 1514-1521
-
-
Starczynski, J.1
-
26
-
-
0037058662
-
Association of a novel single nucleotide polymorphism, G(-248)A, in the 5′-UTR of BAX gene in chronic lymphocytic leukemia with disease progression and treatment resistance
-
Saxena, A., Moshynska, O., Sankaran, K., Viswanathan, S. & Sheridan, D. P. Association of a novel single nucleotide polymorphism, G(-248)A, in the 5′-UTR of BAX gene in chronic lymphocytic leukemia with disease progression and treatment resistance. Cancer letters 187, 199-205 (2002).
-
(2002)
Cancer Letters
, vol.187
, pp. 199-205
-
-
Saxena, A.1
Moshynska, O.2
Sankaran, K.3
Viswanathan, S.4
Sheridan, D.P.5
-
27
-
-
33846004731
-
Association of a novel regulatory polymorphism (-938C> A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia
-
Nuckel, H. et al. Association of a novel regulatory polymorphism (-938C> A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood 109, 290-297, doi: 10.1182/blood-2006-03-007567 (2007).
-
(2007)
Blood
, vol.109
, pp. 290-297
-
-
Nuckel, H.1
-
28
-
-
34247261624
-
Bax gene G(-248)A promoter polymorphism is associated with increased lifespan of the neutrophils of patients with osteomyelitis
-
Ocana, M. G. et al. Bax gene G(-248)A promoter polymorphism is associated with increased lifespan of the neutrophils of patients with osteomyelitis. Genetics in medicine: official journal of the American College of Medical Genetics 9, 249-255, doi: 10.1097GIM.0b013e318039b23d (2007).
-
(2007)
Genetics in Medicine: Official Journal of the American College of Medical Genetics
, vol.9
, pp. 249-255
-
-
Ocana, M.G.1
-
29
-
-
35649024810
-
Understanding cisplatin resistance using cellular models
-
Stordal, B. & Davey, M. Understanding cisplatin resistance using cellular models. IUBMB life 59, 696-699, doi: 10.1080/15216540701636287 (2007).
-
(2007)
IUBMB Life
, vol.59
, pp. 696-699
-
-
Stordal, B.1
Davey, M.2
-
30
-
-
0022379447
-
The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining
-
Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E. & Croce, C. M. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229, 1390-1393 (1985).
-
(1985)
Science
, vol.229
, pp. 1390-1393
-
-
Tsujimoto, Y.1
Gorham, J.2
Cossman, J.3
Jaffe, E.4
Croce, C.M.5
-
31
-
-
0023779204
-
Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma
-
Seto, M. et al. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. The EMBO journal 7, 123-131 (1988).
-
(1988)
The EMBO Journal
, vol.7
, pp. 123-131
-
-
Seto, M.1
-
32
-
-
0027286622
-
A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter
-
Young, R. L. & Korsmeyer, S. J. A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter. Molecular and cellular biology 13, 3686-3697 (1993).
-
(1993)
Molecular and Cellular Biology
, vol.13
, pp. 3686-3697
-
-
Young, R.L.1
Korsmeyer, S.J.2
-
33
-
-
4544375763
-
Identification of variants in cyclin D1 (CCND1) and B-cell CLL/lymphoma 2 (BCL2)
-
Park, B. L. et al. Identification of variants in cyclin D1 (CCND1) and B-Cell CLL/lymphoma 2 (BCL2). Journal of human genetics 49, 449-454, doi: 10.1007/s10038-004-0173-0 (2004).
-
(2004)
Journal of Human Genetics
, vol.49
, pp. 449-454
-
-
Park, B.L.1
-
34
-
-
80052961223
-
Regulatory BCL2 promoter polymorphism (-938C> A) is associated with adverse outcome in patients with prostate carcinoma
-
Bachmann, H. S. et al. Regulatory BCL2 promoter polymorphism (-938C> A) is associated with adverse outcome in patients with prostate carcinoma. International journal of cancer. Journal international du cancer 129, 2390-2399, doi: 10.1002/ijc.25904 (2011).
-
(2011)
International Journal of Cancer. Journal International du Cancer
, vol.129
, pp. 2390-2399
-
-
Bachmann, H.S.1
-
35
-
-
66149168916
-
The regulatory BCL2 promoter polymorphism (-938C> A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma
-
Lehnerdt, G. F. et al. The regulatory BCL2 promoter polymorphism (-938C> A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 20, 1094-1099, doi: 10.1093/annonc/mdn763 (2009).
-
(2009)
Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO
, vol.20
, pp. 1094-1099
-
-
Lehnerdt, G.F.1
-
36
-
-
35348870611
-
The AA genotype of the regulatory BCL2 promoter polymorphism (938C> A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients
-
Bachmann, H. S. et al. The AA genotype of the regulatory BCL2 promoter polymorphism (938C> A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients. Clinical cancer research: an official journal of the American Association for Cancer Research 13, 5790-5797, doi: 10.1158/1078-0432.CCR-06-2673 (2007).
-
(2007)
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
, vol.13
, pp. 5790-5797
-
-
Bachmann, H.S.1
-
37
-
-
76649120871
-
Association of the AA genotype of the BCL2 (-938C> A) promoter polymorphism with better survival in ovarian cancer
-
Heubner, M. et al. Association of the AA genotype of the BCL2 (-938C> A) promoter polymorphism with better survival in ovarian cancer. The International journal of biological markers 24, 223-229 (2009).
-
(2009)
The International Journal of Biological Markers
, vol.24
, pp. 223-229
-
-
Heubner, M.1
-
39
-
-
0037050735
-
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines
-
Sartorius, U. A. & Krammer, P. H. Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. International journal of cancer. Journal international du cancer 97, 584-592 (2002).
-
(2002)
International Journal of Cancer. Journal International du Cancer
, vol.97
, pp. 584-592
-
-
Sartorius, U.A.1
Krammer, P.H.2
-
40
-
-
9144222021
-
Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small-cell lung cancer
-
Han, J. Y. et al. Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small-cell lung cancer. Medical oncology 20, 355-362, doi: 10.1385/MO:20:4:355 (2003).
-
(2003)
Medical Oncology
, vol.20
, pp. 355-362
-
-
Han, J.Y.1
-
41
-
-
0032055269
-
Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma
-
Fontanini, G. et al. Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma. European journal of cancer 34, 718-723 (1998).
-
(1998)
European Journal of Cancer
, vol.34
, pp. 718-723
-
-
Fontanini, G.1
-
42
-
-
0041343301
-
Role of Bcl-2 as a prognostic factor for survival in lung cancer: A systematic review of the literature with metaanalysis
-
Martin, B. et al. Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with metaanalysis. British journal of cancer 89, 55-64, doi: 10.1038/sj.bjc.6601095 (2003).
-
(2003)
British Journal of Cancer
, vol.89
, pp. 55-64
-
-
Martin, B.1
-
43
-
-
0029902618
-
The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas
-
Chou, D. et al. The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas. Cancer genetics and cytogenetics 88, 136-140 (1996).
-
(1996)
Cancer Genetics and Cytogenetics
, vol.88
, pp. 136-140
-
-
Chou, D.1
-
44
-
-
0036190881
-
Expression of Bcl-x, Bcl-2, Bax, and Bak in endarterectomy and atherectomy specimens
-
Saxena, A., McMeekin, J. D. & Thomson, D. J. Expression of Bcl-x, Bcl-2, Bax, and Bak in endarterectomy and atherectomy specimens. The Journal of pathology 196, 335-342, doi: 10.1002/path.1040 (2002).
-
(2002)
The Journal of Pathology
, vol.196
, pp. 335-342
-
-
Saxena, A.1
McMeekin, J.D.2
Thomson, D.J.3
-
45
-
-
0036392126
-
Bax-induction gene therapy of pancreatic cancer
-
Pirocanac, E. C. et al. Bax-induction gene therapy of pancreatic cancer. The Journal of surgical research 106, 346-351 (2002).
-
(2002)
The Journal of Surgical Research
, vol.106
, pp. 346-351
-
-
Pirocanac, E.C.1
-
46
-
-
15744399807
-
Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability
-
Miquel, C. et al. Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability. American journal of clinical pathology 123, 562-570, doi: 10.1309/JQ2X-3RV3-L8F9-TGYW (2005).
-
(2005)
American Journal of Clinical Pathology
, vol.123
, pp. 562-570
-
-
Miquel, C.1
-
47
-
-
0344348993
-
Analysis of the p53/BAX pathway in colorectal cancer: Low BAX is a negative prognostic factor in patients with resected liver metastases
-
Sturm, I. et al. Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 17, 1364-1374 (1999).
-
(1999)
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
, vol.17
, pp. 1364-1374
-
-
Sturm, I.1
-
48
-
-
34547136180
-
Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy
-
Kang, S. Y. et al. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. Clinical cancer research: an official journal of the American Association for Cancer Research 13, 4146-4153, doi: 10.1158/1078-0432.CCR-06-3063 (2007).
-
(2007)
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
, vol.13
, pp. 4146-4153
-
-
Kang, S.Y.1
-
49
-
-
33750584219
-
Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer
-
Porebska, I. et al. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. In vivo 20, 599-604 (2006).
-
(2006)
Vivo
, vol.20
, pp. 599-604
-
-
Porebska, I.1
-
50
-
-
54949143174
-
Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with nonsquamous histology
-
Jeong, S. H. et al. Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with nonsquamous histology. Japanese journal of clinical oncology 38, 661-669, doi: 10.1093/jjco/hyn089 (2008).
-
(2008)
Japanese Journal of Clinical Oncology
, vol.38
, pp. 661-669
-
-
Jeong, S.H.1
-
51
-
-
84858187016
-
Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma
-
Anvari, K. et al. Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma. Urology journal 9, 381-388 (2012).
-
(2012)
Urology Journal
, vol.9
, pp. 381-388
-
-
Anvari, K.1
-
52
-
-
84866749511
-
The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma
-
Yigit, S. et al. The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma. Neoplasma 59, 475-485, doi: 10.4149/neo-2012-061 (2012).
-
(2012)
Neoplasma
, vol.59
, pp. 475-485
-
-
Yigit, S.1
-
53
-
-
84862584533
-
The effect of raloxifene on Bax protein expression in breast carcinomas of postmenopausal women
-
Lopes-Costa, P. V., dos Santos, A. R. & da Silva, B. B. The effect of raloxifene on Bax protein expression in breast carcinomas of postmenopausal women. Diagnostic cytopathology 40, 570-574, doi: 10.1002/dc.21580 (2012).
-
(2012)
Diagnostic Cytopathology
, vol.40
, pp. 570-574
-
-
Lopes-Costa, P.V.1
Dos Santos, A.R.2
Da Silva, B.B.3
-
54
-
-
84885817813
-
Lack of association between Bax promoter (-248G> A) single nucleotide polymorphism and susceptibility towards cancer: Evidence from a meta-analysis
-
Sahu, S. K. & Choudhuri, T. Lack of association between Bax promoter (-248G> A) single nucleotide polymorphism and susceptibility towards cancer: evidence from a meta-analysis. PloS one 8, e77534, doi: 10.1371/journal.pone.0077534 (2013).
-
(2013)
PLoS One
, vol.8
, pp. e77534
-
-
Sahu, S.K.1
Choudhuri, T.2
-
55
-
-
8944263468
-
Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems
-
Perego, P. et al. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer research 56, 556-562 (1996).
-
(1996)
Cancer Research
, vol.56
, pp. 556-562
-
-
Perego, P.1
-
56
-
-
0029917541
-
Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2
-
Zha, H., Aime-Sempe, C., Sato, T. & Reed, J. C. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. The Journal of biological chemistry 271, 7440-7444 (1996).
-
(1996)
The Journal of Biological Chemistry
, vol.271
, pp. 7440-7444
-
-
Zha, H.1
Aime-Sempe, C.2
Sato, T.3
Reed, J.C.4
-
57
-
-
0028834138
-
Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: Evidence for a novel mechanism of regulating Bcl-2 family protein function
-
Bodrug, S. E. et al. Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell death and differentiation 2, 173-182 (1995).
-
(1995)
Cell Death and Differentiation
, vol.2
, pp. 173-182
-
-
Bodrug, S.E.1
|